UK/INDIA - Pharmaceutical firm, Novartis folded under pressure from pension funds and chose not to appeal against a lost legal battle against the Indian government.
Pension funds protested against the firm's actions labelling it "unfair" following an argument that arose after Novartis challenged a provision in Indian law stating patent monopolies would be awar...
To continue reading this article...
Join Professional Pensions
Become a Professional Pensions Lite Member today
- Three complimentary articles per month covering the latest real-time news, analysis and opinion from the industry
- Receive important and breaking news stories via our two daily news alerts
- Hear from industry experts and other forward-thinking leaders
Are you a trustee, investment consultant or in-house pension and benefit scheme professional? You can apply for full complimentary access here